Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer-related molecular mechanisms research, MicroRNA in disease regulation, Circular RNAs in diseases, and RNA modifications and cancer.
Dermoscopy-guided sampling improves the diagnostic yield of fungal culture for onychomycosis: a comparative study
Prognostic Nomogram for Ovarian Cancer Patients on First-Line Maintenance Therapy With PARP Inhibitors: A Retrospective Cohort Study.
Ultralight, superior stability and inner hydrophobic cement foam prepared with surface-modified inorganic particles-stabilized bubbles
A novel PDE4A inhibitor suppresses hepatocellular carcinoma progression through activating the cAMP-induced PKA pathway
Bioinspired Glycosylpyridinium Donors for Mild and Stereoselective Glycosylation
A microbiota-tryptophol-AhR axis mediates the gut-kidney protective effects of Hushen Tongfengtai Granules in hyperuricemic nephropathy
Identification and Validation of <scp>miR</scp> ‐206‐3p Targeting <scp>WT</scp> ‐1 Promotes Membranous Nephropathy Through a Comprehensive Bioinformatics and Machine Learning Algorithm
Bone marrow mesenchymal stem cell-derived exosomes ameliorate intervertebral disc degeneration by regulating HMGB1 acetylation via SIRT6
Integrated analysis of phenotypic and SSR data reveals the genetic structure differentiation of wild Rhododendron mariae Hance populations in Guangdong and the driving factors for conservation planning
Predictive performance of the SOFA 2.0 score for in-hospital mortality in patients with heat stroke: a multicenter, data-driven subphenotype study
Revisiting therapeutic options against resistant klebsiella pneumoniae infection: Phage therapy is key
MLKL as an emerging machinery for modulating organelle dynamics: regulatory mechanisms, pathophysiological significance, and targeted therapeutics
Targeting HPV for the prevention, diagnosis, and treatment of cervical cancer.
Efficacy and safety of tenofovir and entecavir in patients with chronic hepatitis B-related cirrhosis: a systematic review and meta-analysis
Optimizing the Follow-Up Interval After Successful Cold Knife Conization of CIN3: A 10-Year Retrospective Cohort Study.
Effects of maternal blood beta-hydroxybutyrate on brown adipose tissue functions and thermogenic and metabolic health in neonatal calves
Influence of Pre-Vaccination HPV Status on Vaccine Effectiveness Among Chinese Women: A Multicenter Cross-Sectional Study.
HELQ upregulates PARP1 to drive platinum resistance and predict therapeutic response in ovarian cancer
Metabolomic and transcriptomic analyses provide insights into the role of MiMYB114 and MiMYC2 in the MeJA-induced regulatory network for mango pericarp coloration
2163P Safety and efficacy of simmitinib in patients(pts) with advanced solid tumors: A phase I study
Supplementary Data from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
Figure S.2 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
Figure S.6 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
Figure S.5 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
Figure S.1 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
Figure S.8 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
Figure S.4 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
Figure S.3 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
Figure S.7 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial